BIO

Bio Rad
NYSE

Real-time Quotes | Nasdaq Last Sale

511.77
-3.91
-0.76%
After Hours: 511.77 0 0.00% 16:00 09/23 EDT
OPEN
513.71
PREV CLOSE
515.68
HIGH
523.76
LOW
510.39
VOLUME
94.84K
TURNOVER
--
52 WEEK HIGH
540.06
52 WEEK LOW
309.38
MARKET CAP
15.19B
P/E (TTM)
7.94
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
10x Genomics: Overvaluation Leads To A Short-Term Hold/Trim Ranking
10x Genomics, Inc. has performed outstandingly well since the COVID-19 induced lows of March, more than doubling in this time.Further, the price has held up in volatile times, showing a slow and steady path up with no significant declines.However, I recently trimmed my position slightly in anticipation of a decline that has been occurring in the broader market.Was I right in this decision, or will the long-term growth potential prevail and continue to support the stock?
Seekingalpha · 11h ago
Should You Invest in Coronavirus ETFs?
MotleyFool.com · 09/06 09:27
The Bio-Rad Laboratories (NYSE:BIO) Share Price Has Gained 267%, So Why Not Pay It Some Attention?
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
Simply Wall St. · 09/02 12:47
Hedge Funds Never Been This Bullish On Bio-Rad Laboratories, Inc. (BIO)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F […]
Insider Monkey · 08/31 16:54
These 10 Stocks Are the Biggest S&P 500 Healthcare Winners of 2020
MotleyFool.com · 08/27 06:30
Dig a little, and you’ll find better stocks than the tech superstars, says Jefferies
Here’s why investors need to start thinking about life beyond the big tech superstars that have propelled markets higher. Jefferies equity analyst Steve...
marketwatch.com · 08/25 15:15
A Look Into Healthcare Sector Value Stocks
What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labeled as a value stock.Below is a
Benzinga · 08/24 16:35
Bio-Rad Laboratories: Poor ROCE Of 3% Hurts Valuation, But The Long-Term Stance Remains
FCF has grown 159% YoY, however ROCE remains sluggish at only 3%, which we feel needs evidence of improvement into Q3.ROCE is ubiquitous with the stock's low valuation, meaning we see the stock as overvalued by a significant amount in the base and upside case.There is an entry opportunity for short-term players using the 50 day SMA as an indicator, to also prevent risk of loss to ~7% selling 3% below the 50DSMA on.We are looking for a pullback of ~10% or more to bolster the short-term case. However, we are happy to wait on the sidelines for a correction in valuation and ROCE.
Seekingalpha · 08/19 14:35
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BIO. Analyze the recent business situations of Bio Rad through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average BIO stock price target is 603.75 with a high estimate of 625.00 and a low estimate of 585.00.
EPS
Institutional Holdings
Institutions: 357
Institutional Holdings: 19.31M
% Owned: 65.06%
Shares Outstanding: 29.68M
TypeInstitutionsShares
Increased
102
1.06M
New
39
278.68K
Decreased
130
1.05M
Sold Out
52
795.01K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-1.14%
Healthcare Equipment & Supplies
-1.44%
Key Executives
Chairman/President/Chief Executive Officer/Director
Norman Schwartz
Chief Financial Officer/Executive Vice President
Ilan Daskal
Chief Operating Officer/Executive Vice President
Andrew Last
Executive Vice President/General Counsel/Secretary
Timothy Ernst
Executive Vice President
Michael Crowley
Executive Vice President
Giovanni Magni
Executive Vice President
Annette Tumolo
Executive Vice President
Dara Wright
Senior Vice President/Chief Accounting Officer
Ajit Ramalingam
Vice President/Treasurer
Ronald Hutton
Lead Director/Independent Director
Gregory Hinckley
Director
Alice Schwartz
Independent Director
Jeffrey Edwards
Independent Director
Melinda Litherland
Independent Director
Arnold Pinkston
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About BIO
Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and markets approximately 6,000 reagents, apparatus and laboratory instruments. Its products are used in research techniques, biopharmaceutical production processes and food testing regimes. Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Bio-Rad Laboratories, Inc. stock information, including NYSE:BIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BIO stock methods without spending real money on the virtual paper trading platform.